检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]无锡市人民医院内分泌科,无锡214023 [2]无锡市第二人民医院骨科,无锡214002
出 处:《中国医药导刊》2013年第7期1152-1153,共2页Chinese Journal of Medicinal Guide
摘 要:目的:探讨糖尿病下肢外周动脉病(PAD)的早期筛查和干预方法,观察预防糖尿病足的效果。方法:选取本院住院的1320名糖尿病患者,用踝肱指数(ABI)、趾肱指数(TBI)来筛选PAD。PAD者,除常规进行糖尿病血糖控制外,住院期间给予复方丹参液和前列地尔液治疗,出院后长期口服复方丹参片。门诊随访:每三个月测定ABI一次。结果:1320名糖尿病患者中PAD阳性326例,经B超证实者321例,其中0.5≤ABI<0.9者278例,0.3≤ABI<0.5者41例,ABI<0.3者2例。321例患者全部得到随访,随访时间2~3年,平均1.8年,PAD由阳性转为阴性者19例,ABI上升0.2及以上者51例,ABI无变化者239例,总有效率95.3%。ABI下降0.2及以上者15例,出现糖尿病足病3例。结论:ABI配合TBI的筛查方法,具有检查无创性、价格低廉、使用方便的特点。Objective: To investigate the methods by Early screening and interfering diabetic lower limb peripheral arterial disease(PAD) in order to observe the result of preventing diabetic foot disease.Methods:1320 cases of hospitalize diabetic were selected to screen PAD by ankle-brachial index(ABI) and teo-brachial index(TBI).Intervention ways:the positive PAD were tested by B ultrasonic in order to be make a definite diagnosis and were treated by complex Danshen injection and Alprostadil injection besides routine blood sugar controlling during the hospitalized time.The complex Danshen pill should be taken orally Post-discharge.Clinic service follow-up: test the ABI once per 3 months.Results: 326 cases is PAD positive of 1320 diabetes mellitus.321 cases were confirmed by B ultrasonic.278 cases ABI were between 0.5 to 0.9,41 cases ABI were between 0.3 to 0.4,2 cases ABI were below 0.3;321 cases were followed-up for 2 to 3 years,19 cases turned from positive to negative,51 cases ABI went up in 0.2 and more,239 cases ABI hadn’t changed.total effective rate was 95.3%;15 cases ABI had descened for 0.2 and more;3 cases caught diabetic foot disease.Conclusions: The screening methods by ABI and TBI has such characteristics as no wound,cost low and use conveniently.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229